Update of progression-free survival (PFS) and correlative biomarker analysis from coBRIM: Phase III study of cobimetinib (cobi) plus vemurafenib (vem) in advanced BRAF-mutated melanoma.-Reference-Cited by-同舟云学术

Update of progression-free survival (PFS) and correlative biomarker analysis from coBRIM: Phase III study of cobimetinib (cobi) plus vemurafenib (vem) in advanced BRAF-mutated melanoma.

Published:2015-05-20 Issue:15_suppl Volume:33 Page:9006-9006
ISSN:0732-183X
Container-title:Journal of Clinical Oncology
language:en
Short-container-title:JCO

Author:

Larkin James M. G.¹,Yan Yibing²,McArthur Grant A.³,Ascierto Paolo Antonio⁴,Liszkay Gabriella⁵,Maio Michele⁶,Mandalà Mario⁷,Demidov Lev V.⁸,Stroyakovskiy Daniil⁹,Thomas Luc¹⁰,De La Cruz-Merino Luis¹¹,Atkinson Victoria¹²,Dutriaux Caroline¹³,Garbe Claus¹⁴,Wongchenko Matthew¹⁵,Rooney Isabelle Anne¹⁶,Chang Ilsung²,Hack Stephen Paul²,Dréno Brigitte¹⁷,Ribas Antoni¹⁸

Affiliation:

1. The Royal Marsden NHS Foundation Trust, London, United Kingdom

2. Genentech, Inc., South San Francisco, CA

3. Peter MacCallum Cancer Centre, East Melbourne, Australia

4. Istituto Nazionale Tumori IRCCS, Naples, Italy

5. National Institute of Oncology, Budapest, Hungary

6. University Hospital of Siena, Siena, Italy

7. Papa Giovanni XXIII, Division of Medical Oncology, Unit of Clinical and Translational Research, Department of Oncology and Hematology, Bergamo, Italy

8. Department of Biotherapy, N. N. Blokhin Russian Cancer Research Center, Moscow, Russia

9. Moscow State Oncology Hospital #62, Moscow, Russia

10. Lyon 1 University Centre Hospitalier Lyon Sud, Pierre Benite, France

11. Hospital Universitario Virgen Macarena, Seville, Spain

12. Princess Alexandra Hospital, Woolloongabba, Australia

13. Hôpital Saint-André, CHU Bordeaux, Bordeaux, France

14. University of Tübingen, Tübingen, Germany

15. Genentech, Inc., South San Francisco, CA

16. Genentech, South San Francisco, CA

17. Nantes University, Nantes, France

18. David Geffen School of Medicine at the University of California, Los Angeles, Los Angeles, CA

Publisher